Federation des caisses Desjardins du Quebec’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-500
Closed -$580 2590
2022
Q2
$580 Hold
500
﹤0.01% 2429
2022
Q1
$540 Hold
500
﹤0.01% 2475
2021
Q4
$360 Hold
500
﹤0.01% 2480
2021
Q3
$451 Hold
500
﹤0.01% 2494
2021
Q2
$830 Hold
500
﹤0.01% 2444
2021
Q1
$1.04K Hold
500
﹤0.01% 2368
2020
Q4
$625 Hold
500
﹤0.01% 2255
2020
Q3
$610 Hold
500
﹤0.01% 2070
2020
Q2
$585 Hold
500
﹤0.01% 2030
2020
Q1
$409 Hold
500
﹤0.01% 2137
2019
Q4
$505 Hold
500
﹤0.01% 2246
2019
Q3
$705 Hold
500
﹤0.01% 2179
2019
Q2
$750 Hold
500
﹤0.01% 2170
2019
Q1
$765 Hold
500
﹤0.01% 1986
2018
Q4
$735 Hold
500
﹤0.01% 1978
2018
Q3
$915 Hold
500
﹤0.01% 2049
2018
Q2
$920 Hold
500
﹤0.01% 2076
2018
Q1
$1K Hold
500
﹤0.01% 2057
2017
Q4
$550 Hold
500
﹤0.01% 2073
2017
Q3
$575 Hold
500
﹤0.01% 2022
2017
Q2
$645 Buy
+500
New +$709 ﹤0.01% 2080

Federation des caisses Desjardins du Quebec's MBII Position: Q3 2022 in Review

Federation des caisses Desjardins du Quebec sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 500 shares — an estimated $580 sold.

Federation des caisses Desjardins du Quebec first reported a position in MBII in Q2 2017 and held it in 21 quarters. The position peaked at $1.04K in Q1 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Federation des caisses Desjardins du Quebec reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 500 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $580.
  • Federation des caisses Desjardins du Quebec first reported a position in Marrone Bio Innovations, Inc. in Q2 2017 and held it in 21 quarters.
  • Federation des caisses Desjardins du Quebec's Marrone Bio Innovations, Inc. position peaked at $1.04K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2022, filed 15 Aug 2024.